YU43528B - Process for obtaining 4-phenyl quinazoline derivatives - Google Patents

Process for obtaining 4-phenyl quinazoline derivatives

Info

Publication number
YU43528B
YU43528B YU2233/82A YU223382A YU43528B YU 43528 B YU43528 B YU 43528B YU 2233/82 A YU2233/82 A YU 2233/82A YU 223382 A YU223382 A YU 223382A YU 43528 B YU43528 B YU 43528B
Authority
YU
Yugoslavia
Prior art keywords
image
obtaining
quinazoline derivatives
phenyl quinazoline
group
Prior art date
Application number
YU2233/82A
Other languages
English (en)
Other versions
YU223382A (en
Inventor
A Hallot
K Biziere
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of YU223382A publication Critical patent/YU223382A/xx
Publication of YU43528B publication Critical patent/YU43528B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/84—Nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Luminescent Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Peptides Or Proteins (AREA)
YU2233/82A 1981-10-21 1982-10-05 Process for obtaining 4-phenyl quinazoline derivatives YU43528B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8119767A FR2514765A1 (fr) 1981-10-21 1981-10-21 Nouveaux derives de la phenyl-4 quinazoline actifs sur le systeme nerveux central

Publications (2)

Publication Number Publication Date
YU223382A YU223382A (en) 1984-10-31
YU43528B true YU43528B (en) 1989-08-31

Family

ID=9263248

Family Applications (1)

Application Number Title Priority Date Filing Date
YU2233/82A YU43528B (en) 1981-10-21 1982-10-05 Process for obtaining 4-phenyl quinazoline derivatives

Country Status (24)

Country Link
US (1) US4499092A (ja)
EP (1) EP0079810B1 (ja)
JP (1) JPS5888369A (ja)
KR (1) KR880001077B1 (ja)
AT (1) ATE17576T1 (ja)
AU (1) AU551938B2 (ja)
CA (1) CA1236102A (ja)
CS (1) CS229692B2 (ja)
DD (1) DD210040A5 (ja)
DE (1) DE3268699D1 (ja)
DK (1) DK156063C (ja)
ES (1) ES8307226A1 (ja)
FI (1) FI73982C (ja)
FR (1) FR2514765A1 (ja)
GR (1) GR76535B (ja)
HU (1) HU187579B (ja)
IE (1) IE53653B1 (ja)
IL (1) IL66960A0 (ja)
NO (1) NO164167C (ja)
NZ (1) NZ202237A (ja)
PT (1) PT75667B (ja)
SU (1) SU1299511A3 (ja)
YU (1) YU43528B (ja)
ZA (1) ZA827516B (ja)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2521144A1 (fr) * 1982-02-08 1983-08-12 Sanofi Sa Nouveaux derives de la piperazinyl-2 phenyl-4 quinazoline possedant des proprietes antidepressives, methode de preparation desdits composes et medicaments en contenant
EP0664128A4 (en) * 1992-10-07 1997-12-17 Sumitomo Pharma PHARMACEUTICAL AGENT FOR INHIBITING TUMORNESCROSE FACTOR PRODUCTION.
JPH11209350A (ja) 1998-01-26 1999-08-03 Eisai Co Ltd 含窒素複素環誘導体およびその医薬
EP1618094B1 (en) * 2003-04-30 2007-09-05 The Institutes for Pharmaceutical Discovery, LLC Substituted heteroaryls as inhibitors of protein tyrosine phosphatases
EP1685115A1 (en) * 2003-11-03 2006-08-02 Warner-Lambert Company LLC Novel norepinephrine reuptake inhibitors for the treatment of central nervous system disorders
AU2006263924A1 (en) * 2005-06-27 2007-01-04 F. Hoffmann-La Roche Ag Chloro-substituted guanidines
US7855194B2 (en) 2006-03-27 2010-12-21 Hoffmann-La Roche Inc. Pyrimidine, quinazoline, pteridine and triazine derivatives
KR20140054433A (ko) 2006-11-22 2014-05-08 스미또모 가가꾸 가부시끼가이샤 사이토카이닌 신호전달을 저해할 수 있는 물질

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA894239A (en) * 1972-02-29 Pfizer Inc. Nitrogen heterocycles
US3305553A (en) * 1965-10-18 1967-02-21 Parke Davis & Co 2-aminoquinazoline derivatives
US3509141A (en) * 1966-09-15 1970-04-28 Ciba Geigy Corp 2-amino-quinazolines
GB1347493A (en) * 1971-02-11 1974-02-27 Aspro Nicholas Ltd Benzazine derivatives
JPS5398997A (en) * 1977-02-09 1978-08-29 Sumitomo Chem Co Ltd Fused pyridine derivertives and process for their preparation

Also Published As

Publication number Publication date
HU187579B (en) 1986-01-28
FI73982B (fi) 1987-08-31
FI73982C (fi) 1987-12-10
DD210040A5 (de) 1984-05-30
EP0079810A1 (fr) 1983-05-25
FR2514765A1 (fr) 1983-04-22
CS229692B2 (en) 1984-06-18
ES516694A0 (es) 1983-07-01
JPS5888369A (ja) 1983-05-26
AU8962882A (en) 1983-04-28
KR840001968A (ko) 1984-06-07
FI823580L (fi) 1983-04-22
ES8307226A1 (es) 1983-07-01
EP0079810B1 (fr) 1986-01-22
DK156063C (da) 1989-11-13
NO164167B (no) 1990-05-28
IL66960A0 (en) 1983-02-23
US4499092A (en) 1985-02-12
NO823491L (no) 1983-04-22
IE822447L (en) 1983-04-21
NO164167C (no) 1990-09-05
DK156063B (da) 1989-06-19
CA1236102A (en) 1988-05-03
FI823580A0 (fi) 1982-10-20
AU551938B2 (en) 1986-05-15
DK465182A (da) 1983-04-22
IE53653B1 (en) 1989-01-04
ATE17576T1 (de) 1986-02-15
NZ202237A (en) 1985-08-30
FR2514765B1 (ja) 1984-04-06
YU223382A (en) 1984-10-31
KR880001077B1 (ko) 1988-06-22
DE3268699D1 (en) 1986-03-06
PT75667B (fr) 1985-01-11
ZA827516B (en) 1983-08-31
GR76535B (ja) 1984-08-10
PT75667A (fr) 1982-11-01
SU1299511A3 (ru) 1987-03-23

Similar Documents

Publication Publication Date Title
HUT50786A (en) Process for producing new condensed heterocyclic compounds and pharmaceutical compositions containing them as active components
DE2963278D1 (en) Amino-pyrimidine-carbanilides, process for their preparation, medicines containing them
DE3366141D1 (en) 1-phenylisoquinoline derivatives, process for their preparation, pharmaceutical compositions containing these compounds and their use
PT77616A (en) Process for preparing imidazolylalkylthien-2-yl-tetrahydropyri-dazines and of pharmaceutical compositions containing the same
AU3923789A (en) Diorganopolysiloxane derivatives, their preparation and their use
NZ216048A (en) Quinolylglycinamide derivatives, and pharmaceutical compositions containing such
YU223382A (en) Process for obtaining phenyl-4-quinazoline derivatives
HUT47430A (en) Process for producing pharmaceutical compositions containing 2-pyrimidinyl-1-piperazine derivatives for treating alcoholizmus
IE56209B1 (en) Piperidinedione derivatives,processing anti-arrythmic activity,for protecting the myocardium,process for their preparation and pharmaceutical compositions containing said derivatives
DE3062340D1 (en) 1-n-alkylsisomicin derivatives, process for their preparation and their use as medicines
DE3463143D1 (en) 1-0-alkyl-3-amino-propan-1.2-diol-2-0-phospholipids, process for producing the same and pharmaceutical preparations containing the same
GR76739B (ja)
IL95166A0 (en) Renin-inhibiting amino oligohydroxy derivatives
HUT54682A (en) Process for producing 13-bromine- and 13,14-dibromine-ergoline derivatives and pharmaceutical preparatives containing these compounds
GR3015706T3 (en) Benzylselenobenzamides of aminopyridines and picolylamines.
HUT44802A (en) Process for producing pseudo-oligosaccharides and pharmaceutical compositions containing them
IL87198A (en) Leukotriene antagonists,a process for the preparation thereof and pharmaceutical compositions containing them
SE7907656L (sv) 3,4-dihydroxikanelaldehydderivat